Poly-C specific ribonuclease activity correlates with increased concentrations of IL-6, IL-8 and STNFR55/TNFR75 in plasma of patients with acute pancreatitis

Journal of Physiology and Pharmacology

Volumn 54, Issue 3, 2003, Pages 439-448

  Naskalski, Jerzy W ^a   Kusnierz Cabala, B ^a   Panek, J ^a   Kedra, B ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acute pancreatitis; Correlation of ribonuclease with cytokines; Interleukin 6; Interleukin 8; Ribonuclease; TNF soluble receptors

Indexed keywords

BIOCHEMICAL MARKER; INTERLEUKIN 6; INTERLEUKIN 8; POLYCYTIDYLIC ACID SPECIFIC RIBONUCLEASE; RIBONUCLEASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 55; TUMOR NECROSIS FACTOR RECEPTOR 75; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME SUBSTRATE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PANCREAS INJURY; PANCREAS NECROSIS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; AMYLASES; ANTIGENS, CD; ENDORIBONUCLEASES; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PANCREATITIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RIBONUCLEASE, PANCREATIC; SEVERITY OF ILLNESS INDEX; SOLUBILITY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141681374     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Reddi KK, Dreiling DA. Polycytidylate hydrolyzing ribonuclease activity of human pancreatic secretions. Biochem Clin 1981; 14: 191-195.
2. Reddi KK, Holland JF. Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci 1976; 43: 2308-2310.
3. Warshaw AL, Fournier PO. Release of ribonuclease from anoxic pancreas. Surgery 1984; 91: 537-540.
4. Kingsnorth A. Role of cytokines and their inhibitors in acute pancreatitis. Gut 1997; 40: 1-4.
5. Chen CC, Wang SS, Lee FY, Chang FY, Lee SD. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999; 94: 213-218.
6. Shimada M, Andoh A, Hata K. IL-6 secretion by human pancreatic periacinar myofibroblasts response to inflammatory mediators. J Immunol 2002; 168: 861-868.
7. Berney T, Gassche Y, Robert J. Serum profiles of interleukin-6, interleukin-8, and interleukin 10 in patients with severe and mild acute pancreatitis. Pancreas 1999; 18: 371-377.
8. Pezilli R, Morselli-Labate AM, Miniero R, Barakat B, Fiocchi M, Cappelletti O. Simultaneous serum assays of lipase and interleukin-6 for early diagnosis and prognosis of acute pancreatitis. Clin Chem 1999; 45: 1762-1767.
9. Hirota M, Nozawa F, Okabe A. Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis. Pancreas 2000; 21: 141-146.
10. Windsor JA. Search for prognostic markers of acute pancreatitis. Lancet 2000; 355: 431-435.
11. Steer ML. The early intra acinar cell events which occur in acute pancreatitis. Pancreas 1998; 17: 31-37.
12. Warshaw AL, Lee KH. Serum ribonuclease elevations and pancreatic necrosis in acute pancreatitis. Surgery 1979; 86: 227-230.
13. Yadav D, Agarwal N, Pitchumoni CS. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol 2002; 97: 1309-1318.
14. Kusnierz-Cabala B, Kedra B, Sierzega M. Current concepts on diagnosis and treatment of acute pancreatitis. Adv Clin Chem. 2003; 37: 47-81.
15. Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA September 11-13 1992. Arch Surg 1993; 128: 586-590.
16. Baron TH, Morgan DE, Desiree E. Current Concepts: Acute necrotizing pancreatitis. N Eng J Med 1999; 340: 1412-1417.
17. Dervenis C, Bassi C. Evidence-based assessment of severity and management of acute pancreatitis. Br J Surgery 2000; 87: 257-258.
18. Lundberg AH, Wubanks JW, Henry J. Trypsin stimulates production of cytokines from peritioneal macrophages in vitro and in vivo. Pancreas 2000; 21: 41-51.
19. Naskalski JW. Determination of ribonuclease activity on serum of patients with pancreatic necrosis. An attempt of extending the enzyme diagnostics of acute pancreatitis. Zeist Med Labor Diagnostik 1989; 30: 425-4331.
20. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000; 47: 546-552.
21. Sakorafas GH, Tsioton AG. Etiology and pathogenesis of acute pancreatitis: current concepts. J Clin Gastroenterol 2000; 30: 343-356.
22. Dembinski A, Warzecha Z, Ceranowicz P, Stachura J, Tomaszewska R, Konturek SJ et al. Pancreatic damage and regeneration in the course of ischemia-reperfusion induced pancreatitis in rats. J Physiol Pharmacol 2001; 52 (2): 221-235.
23. Warzecha Z, Dembiński A, Konturek PC, Ceranowicz P, Konturek SJ, Tomaszewska R, et. al. Hepatocyte growth factor attenuates pancreatic damage in cerulein-induced pancreatitis in rats. Europ J Pharmacol 2001; 430: 113-121.
24. Hynninen M, Valtonen M, Markkanen H. Intramucosal pH and endotoxin and cytokine release in severe acute pancreatitis. Shock 2000; 13: 79-82.
25. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J. Inflammatory mediators in acute pancreatitis. J Pathol 2000; 190: 117-125.
26. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9: 401-410.
27. Sandberg AA, Borgstrom A. Early prediction of severity in acute pancreatitis. Is this possible? JOP 2002; 3: 116-125.